Primary tabs

Alleviating Human and Animal African Sleeping Sickness

Paul Dyson of Swansea University in the United Kingdom will work to control the incidence of sleeping sickness in humans, which is caused by the Trypanosome parasite transmitted by tsetse flies, by genetically modifying a fly gut bacterium to deliver double-stranded (ds) RNAs to block two important parasite proteins. Trypanosomes mature in the flies, thereby gaining the capacity to infect mammals. He will engineer the bacteria and introduce them into tsetse flies, then test the capacity of the dsRNAs to inhibit their target proteins in trypanosomes. This approach could lead to long-term control of this disease as the bacteria are maternally transmitted to the offspring.

Grant ID
OPP1098718
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False